ULB, CHU Saint-Pierre, Hôpital Erasme, ULiège - FNRS

" The project investigates the immune responses to SARS-CoV-2 infection in humans. Cohorts of patients and contacts are recruited and followed-up during several months following infection. Using systems serology and systems biology approaches, the quality and dynamics of antibody and cellular responses are analysed to identify correlates of protection against severe disease and to determine the duration of natural immunity to the virus. The project should provide insight in the host response to SARS-CoV-2 and should help define deconfinement strategies and develop prophylactic and therapeutic interventions against COVID-19. "
Funding: COVID 19 - ULB
Contact: Arnaud Marchant: This email address is being protected from spambots. You need JavaScript enabled to view it. Stanislas Goriely: This email address is being protected from spambots. You need JavaScript enabled to view it.

ULiège CEIB
" Expert services for Federal Agency of Drug and Medical products "
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

ULB - Fablab ULB
" A multidisciplinary team at the Fablab ULB (Université Libre de Bruxelles, Belgium) has developed and produced different open-source emergency protective solutions against Covid-19 for hospitals and caregivers. Most of these solutions have been developed within the global fablab network using digital fabrication machines (laser cutter, 3D printers,...) and open-source documentation which allowed other fablabs in the world to develop and produced these solutions locally. Face Protective Masks Face Protective Masks have been developed to protect caregivers from aerosol projection. Thanks to a lot of help (other fablabs, architectural offices, students, volunteers,...), we have produced more than 50 000 Protective Face Shields and distributed them in hospitals and to other caregivers. This project was made in collaboration with Fab-C (Charleroi), fablab Yourlab (Andenne) and the Hospital CHU Saint-Pierre in Brussels and supported by the Michel Crémer Foundation. Swabs...

Read more: Denis Terwagne, Professor - Victor Lévy, Professor - Alain Delchambre, Professor - Nicolas De Coster

ULiège
" Development of Methods for Mask and N95 Decontamination (the DeMaND study) and reuse for healthcare workers at the frontline The aim of this study is to identify and test, simple low-cost safe decontamination methods to enable medical masks and N95/ FFP2 respirators reuse in healthcare settings where there are critical shortages. "
Funding: Open Philanthropy
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it., This email address is being protected from spambots. You need JavaScript enabled to view it. 

ULiège
"DECONTAMINATION AND REUSE OF SURGICAL MASKS AND FILTERING FACEPIECE RESPIRATORS The global test protocol, presented in this project, aims to assess: a) the effectiveness of several decontamination methods with regard to integrity (""barrier"" function) and the quality of surgical masks and filtering facepiece respirators FFP2/N95; b) the efficacy of these decontamination methods on the inactivation of a coronavirus, similar to the SARS-CoV-2 virus present on surgical masks and filtering facepiece respirators FFP2/N95. Moreover, the present project aims to set up a consortium of companies and laboratories to meet the diverse and varied requests for ""reuse"" of various medical protective equipment (masks, filters, clothing, etc.) linked with the environmental approach."
Funding: Walloon Government
Contact: https://www.news.uliege.be/cms/c_11717821/fr/l-uliege-coordonne-le-projet-wallon-de-decontamination-des-masques-chirurgicaux-et-de-protection-respiratoire-ffp2...

Read more: Eric Haubruge, Professeur ordinaire - Etienne Thiry, Professeur ordinaire - Georges Daube,...

ULiège
“ Microsys Laboratory takes part in 3D printing of protective visor elements for care staff. This activity is enabled by the recent acquisition of a high-performance 3D printer and takes place within the framework of an ongoing project aimed at developing technologies in the field of microsystems, sensors and packaging.”
Funding: Projets compléments FEDER Micro+ (conventions 1510608 et 1510609)
Contact: Francois Dupont - This email address is being protected from spambots. You need JavaScript enabled to view it.

UCLouvain
" This research project aims at studying the conditions under which the modern welfare state could build a kind of epidemics insurance, while paying a particular attention to the issue of fairness. The global objective of saving lives may be associated to policies that have undesirable distributive effects, against ideals of social justice. The project aims at finding ways to make mass prevention and equity compatible. "
Funding: This project will be part of my research load at UCLouvain, within the Hoover Chair in Economic ans Social Ethics.
Publication References: Fleurbaey, M., Ponthiere, G. (2013). Prevention against Equality ? Journal of Public Economics. Fleurbaey, M., Leroux, ML, Ponthiere, G. (2014). Compensating the dead. Journal of Mathematical Economics. Fleurbaey, M., Leroux, ML., Pestieau, P., Ponthiere G. (2016). Fair retirement under risk lifetime. International Economic Review. Leroux, ML., Ponthiere, G. (2018). Working time regulations, unequal lifetime and...

Read more: Gregory Ponthiere, Professor

Equaly sa
" Novel methods to prevent and treat Covid-19 viral infection by inhibiting virus entry "
Funding: not disclosed 

UMONS
" The 2019 coronavirus disease (COVID-19) pandemic is a public health emergency of international concern. Authorities and population are facing a global health crisis which pose a challenge to adapt quickly and effectively. The aim of this preliminary study was to survey the general public in Belgium to better understand their levels of psychological impact, anxiety and stress during the initial stage of containment. The data also explored tips and tricks immediately adopt by the population to manage containment. From 20 March to 28 March 2020, we conducted an online survey using snowball sampling techniques on social network. The online survey collected information on demographic data, stress level in the past 7 days, knowledge and concerns about COVID-19 and the impact of using technologies for taking information and stay connected to others, precautionary measures (tips and tricks) during the beginning of containment, and additional information required with respect to...

Read more: Jennifer Denis, PhD in psychology research and teaching associate

Chemical Engineering ULiège & CRM Group - FNRS
" The Chemical Engineering Department of the Faculty of Applied Sciences of the University of Liège has been producing protective visors by 3D printing since April 4 and provides various hospital services (CHU, Citadelle, Bois de l'Abbaye), rest homes, associations and health care practices. A team of members of the Department has been set up to ensure 24-hour production, which means that up to 90 visors can now be produced per day depending on demand. As the days go by, production optimization continues to lighten components, produce faster and reduce the amount of raw material needed. The Department also receives visor supports produced by 3D printing by people from the Metallurgical Research Centre (CRM), a privileged partner of the Faculty, in order to equip them with plastic sheets to produce visors. This equipment is then distributed with the rest of the production from Chemical Engineering. The milestone of 1000 visors...

Read more: Jérôme Schruyers, Researcher - Alexandre Léonard, Research logistician - Carlos Mendoza, Postdoc -...

EXO Biologics
" EXO Biologics plans to extend its research and development program towards the COVID-19 crisis by using its unique and disruptive technology based on Extracellular Vesicles. These nanometer size particles are gaining momentum in the scientific community as potential alternatives to stem cell and biologic drugs therapies in the fields of immunology, neurology, oncology, cardiology, gastroenterology among others. EXO Biologics has 12 years of experience in cell-based regenerative medicine and 8 years of experience in Extracellular Vesicles. Our advancements in research will play an important role for our company mission to provide affordable and accessible therapies to patients with unmet medical needs. "
Contact: This email address is being protected from spambots. You need JavaScript enabled to view it.

ULiège
" Collective production of 3D printed face shields and mask clips to be distributed to health care professionals. About 400 face shields were produced and distributed within a month. Collaboration involving CARE-FEPEX and FVM skill lab. "
Contact: Ludovic Martinelle This email address is being protected from spambots. You need JavaScript enabled to view it. 04 366 40 39

Bordet Institute
" On April 11th, 2020, four patients hospitalized for more than 7 days developed fever some of them respiratory symptoms compatible with Covid-19 infection and were detected positive for SARS-CoV2. A 5th patient was also detected positive , had minor symptoms and was admitted 2 days earlier for collecting PBSC As a consequence of this mini-outbreak a screening of healthcare workers at this Unit revealed 2 staff members positive for SARS-CoV2. Severe acute respiratory distress syndrome Coronavirus 2(SARS-CoV2), causing Covid19 pandemic is rapidly spreading from person-to-person, via respiratory droplets, direct contact with mucous membranes or indirect contact through touching infected surfaces and then touching own eyes, nose or mouth. Airborne transmission after generated aerosols (intubation, bronchoscopy, tracheal aspiration,…) have been previously reported for other Coronaviruses(SARS-CoV1, MERS) and has been postulated for SARS-Cov2. In critical units such as the...

Read more: Mickael Aoun, Infectiologist

UCLouvain/Cliniques universitaires Saint-Luc 
" COVID-19 pandemic has an important impact on the health care provided by the anesthesiologists. Different societies of anesthesiology have provided guidelines and recommendations on how to manage patients who have been tested positive for COVID-19 or suspected to be infected. It is therefore important to know whether these guidelines have been implemented or were possible to be implemented. Otherwise patients who are presenting COVID-19 often show pulmonary complications. The airway management and the ventilation management of these patients can be therefore challenging and can possibly influence their outcome. It is thus important to obtain a large database with information about the characteristics of these patients, how these patients have been managed and their in-hospital outcome. Information regarding the correct implementation of guidelines is as well necessary for future guidance of health care providers. "
Funding: None
Contact...

Read more: Mona Momeni, MD, PhD

ULiège 
" There is a critical need for therapeutic solutions against SARS-CoV-2. Before implementing innovative treatments in human medicine, a first screening of the antiviral or immunomodulatory activity should be performed by in vitro and in vivo methods. To this aim, we developed in vitro (cell culture) and in vivo (hamsters and mice) models of SARS-CoV-2 infection. We developed an in vitro (cell culture) and in vivo (hamsters and mice) to screen antiviral or immunomodulatory molecules, in partnership with colleagues from the ULiège hospital and the GIGA research center. We also validate the inactivation protocols to facilitate the diagnostic workflow, in partnership with the Federal task force. "
Funding: Currently no funding. We applied to the "Crédits urgents de recherche" call.
Contact: Mutien Garigliany, DVM, PhD, Dipl. ECVP Professor Department of Pathology Faculty of Veterinary Medicine Centre for Fundamental and Applied Research for Animals & Health (FARAH) Liège...

Read more: Mutien Garigliany, Professor - Daniel Desmecht, Professor